Literature DB >> 9602624

The nanophthalmic macula.

J C Serrano1, P R Hodgkins, D S Taylor, G A Gole, A Kriss.   

Abstract

AIMS: To define an unusual macular appearance found in association with nanophthalmos.
METHODS: A case review.
RESULTS: Seven children (aged 8 months to 17 years) with nanophthalmos were examined. They all exhibited the same clinical findings of an unusual yellow macula appearance with retinal folds and crowded optic discs. Visual electrophysiology performed in four cases was normal.
CONCLUSION: A distinctive yellow macular pigmentation with associated chorioretinal folds and crowded optic discs is present in nanophthalmos. It is proposed that the retinal folds are due to a disparity between scleral and retinal growth while the macula discoloration is due to a congenital abnormality in arrangement or position of the luteal pigment and is not degenerative. Included in this case series is the second case in the literature of nanophthalmos associated with Kenny's syndrome. Inheritance of nanophthalmos appears to be autosomal recessive.

Entities:  

Mesh:

Year:  1998        PMID: 9602624      PMCID: PMC1722527          DOI: 10.1136/bjo.82.3.276

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  34 in total

1.  Familial nanophthalmos.

Authors:  H E Cross; F Yoder
Journal:  Am J Ophthalmol       Date:  1976-03       Impact factor: 5.258

2.  Bilateral nanophthalmos.

Authors:  S E Hirsch; S R Waltman; F G LaPiana
Journal:  Arch Ophthalmol       Date:  1973-04

3.  Nanophthalmos.

Authors:  R B O'Grady
Journal:  Am J Ophthalmol       Date:  1971-06       Impact factor: 5.258

4.  Dwarfism and cortical thickening of tubular bones. Transient hypocalcemia in a mother and son.

Authors:  F M Kenny; L Linarelli
Journal:  Am J Dis Child       Date:  1966-02

5.  The management of glaucoma in nanophthalmos.

Authors:  F P Calhoun
Journal:  Trans Am Ophthalmol Soc       Date:  1975

6.  Ocular findings in Kenny's syndrome.

Authors:  J R Boynton; T R Pheasant; B L Johnson; D B Levin; B W Streeten
Journal:  Arch Ophthalmol       Date:  1979-05

7.  Oculodentodigital dysplasia syndrome with angle-closure glaucoma.

Authors:  H S Sugar
Journal:  Am J Ophthalmol       Date:  1978-07       Impact factor: 5.258

8.  Nanophthalmos: a perspective on identification and therapy.

Authors:  O S Singh; R J Simmons; R J Brockhurst; C L Trempe
Journal:  Ophthalmology       Date:  1982-09       Impact factor: 12.079

9.  Biochemical studies of glycosaminoglycans in nanophthalmic sclera.

Authors:  M Kawamura; S Tajima; N Azuma; H Katsura; K Akiyama
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-02       Impact factor: 3.117

10.  Excessive hypermetropia: review and case report documented by echography.

Authors:  M Fried; G Meyer-Schwickerath; A Koch
Journal:  Ann Ophthalmol       Date:  1982-01
View more
  16 in total

1.  Clinical features of posterior microphthalmic and nanophthalmic eyes.

Authors:  Jing-Jing Liu; Yi-Ye Chen; Xiang Zhang; Pei-Quan Zhao
Journal:  Int J Ophthalmol       Date:  2018-11-18       Impact factor: 1.779

2.  A 61-year-old man with cystoid macular edema and chorioretinal folds after cataract surgery.

Authors:  Andrew Lee; Sandra R Montezuma
Journal:  Digit J Ophthalmol       Date:  2017-08-29

3.  Novel membrane frizzled-related protein gene mutation as cause of posterior microphthalmia resulting in high hyperopia with macular folds.

Authors:  Rosemarie A Wasmann; Jolien S Klein Wassink-Ruiter; Olof H Sundin; Elisa Morales; Joke B G M Verheij; Jan Willem R Pott
Journal:  Acta Ophthalmol       Date:  2013-06-07       Impact factor: 3.761

4.  Extreme hyperopia is the result of null mutations in MFRP, which encodes a Frizzled-related protein.

Authors:  Olof H Sundin; Gregory S Leppert; Eduardo D Silva; Jun-Ming Yang; Sharola Dharmaraj; Irene H Maumenee; Luisa Coutinho Santos; Cameron F Parsa; Elias I Traboulsi; Karl W Broman; Cathy Dibernardo; Janet S Sunness; Jeffrey Toy; Ethan M Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-23       Impact factor: 11.205

5.  Autosomal-recessive posterior microphthalmos is caused by mutations in PRSS56, a gene encoding a trypsin-like serine protease.

Authors:  Andreas Gal; Isabella Rau; Leila El Matri; Hans-Jürgen Kreienkamp; Susanne Fehr; Karim Baklouti; Ibtissem Chouchane; Yun Li; Monika Rehbein; Josefine Fuchs; Hans C Fledelius; Kaj Vilhelmsen; Daniel F Schorderet; Francis L Munier; Elsebet Ostergaard; Debra A Thompson; Thomas Rosenberg
Journal:  Am J Hum Genet       Date:  2011-03-11       Impact factor: 11.025

6.  High-hyperopia database, part I: clinical characterisation including morphometric (biometric) differentiation of posterior microphthalmos from nanophthalmos.

Authors:  N Relhan; S Jalali; N Pehre; H L Rao; U Manusani; L Bodduluri
Journal:  Eye (Lond)       Date:  2015-10-23       Impact factor: 3.775

7.  Developmental basis of nanophthalmos: MFRP Is required for both prenatal ocular growth and postnatal emmetropization.

Authors:  Olof H Sundin; Sharola Dharmaraj; Imran A Bhutto; Takuya Hasegawa; D Scott McLeod; Carol A Merges; Eduardo D Silval; Irene H Maumenee; Gerard A Lutty
Journal:  Ophthalmic Genet       Date:  2008-03       Impact factor: 1.803

8.  A clinical and molecular genetic study of a rare dominantly inherited syndrome (MRCS) comprising of microcornea, rod-cone dystrophy, cataract, and posterior staphyloma.

Authors:  M A Reddy; P J Francis; V Berry; K Bradshaw; R J Patel; E R Maher; R Kumar; S S Bhattacharya; A T Moore
Journal:  Br J Ophthalmol       Date:  2003-02       Impact factor: 4.638

9.  Optical coherence tomography findings of retinal folds in nanophthalmos.

Authors:  F Nilüfer Yalçındağ; Huban Atilla; Figen Batıoğlu
Journal:  Case Rep Ophthalmol Med       Date:  2012-01-23

10.  Mutations in a novel serine protease PRSS56 in families with nanophthalmos.

Authors:  Andrew Orr; Marie-Pierre Dubé; Juan C Zenteno; Haiyan Jiang; Geraldine Asselin; Susan C Evans; Aurore Caqueret; Hesham Lakosha; Louis Letourneau; Julien Marcadier; Makoto Matsuoka; Christine Macgillivray; Mathew Nightingale; Simon Papillon-Cavanagh; Scott Perry; Sylvie Provost; Mark Ludman; Duane L Guernsey; Mark E Samuels
Journal:  Mol Vis       Date:  2011-07-12       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.